Our data shows that fibrinogen Aα Thr312Ala polymorphism is an independent risk factor of CTEPH due to fibrin resistance to lysis by plasmin and the fact that it is related to the fibrinogen Aα Thr312Ala genotypes in CTEPH patients. Here, PLG is linked to chronic thromboembolic pulmonary hypertension.